603658 Stock Overview
Engages in the research and development, production, marketing, sale, and service of clinical diagnostic products.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Autobio Diagnostics Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥42.26 |
52 Week High | CN¥66.36 |
52 Week Low | CN¥39.73 |
Beta | -0.14 |
11 Month Change | -5.94% |
3 Month Change | -25.32% |
1 Year Change | -17.70% |
33 Year Change | -38.91% |
5 Year Change | -28.74% |
Change since IPO | 161.61% |
Recent News & Updates
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet
Jul 18Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?
May 21Shareholder Returns
603658 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | 5.5% | 1.5% | -0.6% |
1Y | -17.7% | -15.6% | -22.0% |
Return vs Industry: 603658 underperformed the CN Medical Equipment industry which returned -15.6% over the past year.
Return vs Market: 603658 exceeded the CN Market which returned -22% over the past year.
Price Volatility
603658 volatility | |
---|---|
603658 Average Weekly Movement | 3.6% |
Medical Equipment Industry Average Movement | 5.2% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 603658's share price has been volatile over the past 3 months.
Volatility Over Time: 603658's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | 5,539 | Zeng Li Yang | www.autobio.com.cn |
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products. It develops immunoassay, biochemistry, and microbiology products, as well as reagents; and instruments, as well as medical laboratory solutions. The company’s immunoassay products AutoLumo A1860 that provides user experience for small and medium size labs; an automated chemiluminescence immunoassay analyzer; AutoLumo A2000 Plus, an automatic chemiluminescence immunoassay analyzer; AutoLumo A1000, an automated chemiluminescence immunoassay analyzer; and LUmo microplate luminometers, PHOmo microplate readers, and iWO and iWO-960 microplate washers.
Autobio Diagnostics Co., Ltd. Fundamentals Summary
603658 fundamental statistics | |
---|---|
Market cap | CN¥24.00b |
Earnings (TTM) | CN¥1.30b |
Revenue (TTM) | CN¥4.50b |
18.9x
P/E Ratio5.5x
P/S RatioIs 603658 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603658 income statement (TTM) | |
---|---|
Revenue | CN¥4.50b |
Cost of Revenue | CN¥1.59b |
Gross Profit | CN¥2.90b |
Other Expenses | CN¥1.60b |
Earnings | CN¥1.30b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
Earnings per share (EPS) | 2.24 |
Gross Margin | 64.54% |
Net Profit Margin | 28.90% |
Debt/Equity Ratio | 8.3% |
How did 603658 perform over the long term?
See historical performance and comparison